CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +18,500 | $2.90 | $54K | 253,744 |
| 2026-09-15 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −18,500 | $37.00 | $685K | 235,244 |
| 2026-09-15 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,500 | 488,801 | ||
| 2026-09-11 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | +5,000 | $3.94 | $20K | 80,754 |
| 2026-09-11 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Option exercise · Stock Option (right to buy) | −5,000 | 33,589 | ||
| 2026-09-02 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +18,500 | $2.90 | $54K | 253,744 |
| 2026-09-02 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −18,500 | $35.12 | $650K | 235,244 |
| 2026-09-02 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,500 | 507,301 | ||
| 2026-08-03 | Boman Nancy Lee Chief Regulatory Officer | Grant or award | +44,987 | 44,987 | ||
| 2026-08-03 | Boman Nancy Lee Chief Regulatory Officer | Grant or award · Stock Option (right to buy) | +63,011 | 63,011 | ||
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +46,250 | $2.90 | $134K | 281,494 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,000 | $40.78 | $41K | 280,494 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −32,550 | $42.07 | $1.4M | 247,944 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −10,500 | $42.86 | $450K | 237,444 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −2,200 | $43.59 | $96K | 235,244 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −46,250 | 525,801 | ||
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,000 | $40.78 | $41K | 197,244 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −32,550 | $42.07 | $1.4M | 164,694 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −10,500 | $42.86 | $450K | 154,194 |
| 2026-07-07 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −2,200 | $43.59 | $96K | 151,994 |
Page 1 of 17 · 321 trades